Related Experiment Video
Updated: May 4, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Live vaccines in solid organ transplant recipients
Rebecca Sturgis1, Lara Danziger-Isakov2, Amy Feldman3
1Cincinnati Children's Hospital Medical Center, Department of Infectious Diseases.
Live vaccines like MMR and varicella are safe and effective for select pediatric solid organ transplant (SOT) recipients, improving protection against vaccine-preventable infections. Further research is needed for adult SOT patients.
Area of Science:
- Immunology
- Transplant Medicine
- Vaccinology
Background:
- Vaccine-preventable infections (VPIs) pose significant risks to solid organ transplant (SOT) recipients.
- Many SOT candidates and recipients have suboptimal vaccination coverage.
- Optimizing vaccination strategies before and after transplantation is crucial due to declining herd immunity.
Purpose of the Study:
- To review current evidence and evolving recommendations for live vaccine administration in SOT candidates and recipients.
- To assess the safety and immunogenicity of live vaccines in this vulnerable population.
- To identify knowledge gaps and areas for future research.
Main Methods:
- Review of modern evidence and evolving recommendations.
- Analysis of accumulating data, primarily from pediatric liver and kidney SOT cohorts.
- Evaluation of multicenter experience with posttransplant live vaccination.
Main Results:
- Vaccination coverage at transplant remains suboptimal, but interventions can improve uptake.
- Posttransplant measles, mumps, rubella (MMR) and varicella (VAR) vaccination is supported by data in select pediatric SOT recipients.
- Updated guidance and clinical practice reflect findings for specific pediatric SOT populations.
Conclusions:
- Live vaccine administration appears feasible and beneficial in carefully selected pediatric SOT recipients.
- Live vaccines may reduce susceptibility to VPIs in this population.
- Further research is essential for adult SOT recipients, non-liver transplant groups, and other live vaccines to define safety, immunogenicity, and optimal timing.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

